Skip to main content

Table 1 General characteristics of study groups

From: Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients

Characteristic/Variable Non-T2D group (n = 15) T2D group (n = 10) p-value
Gender 60% (female)/40% (male) 60% (female)/40% (male) 1.00
Age (year) 54.7 ± 10.0 [49.2 - 60.3] 54.9 ± 8.7 [48.7 - 61.1] 0.89
Hemoglobin (g/dL) 13.6 ± 1.1 [13.0 - 14.3] 13.6 ± 1.4 [12.6 - 14.6] 0.97
Hematocrit (%) 41.1 ± 2.7 [39.6 - 42.7] 40.4 ± 4.0 [37.5 - 43.3] 0.56
Body mass index (kg/m2) * 26.6 ± 3.7 [24.5 - 28.7] 33,7 ± 4,0 [30.8 - 36.6] 0.00
Fasting glucose (mg/dL) * 92.9 ± 9.2 [87.9 -98.0] 167.8 ± 64.0 [117.8 - 258.2] 0.00
HbA1c (%) * 5.8 ± 0.3 [5.6 - 6.0] 9.3 ± 2.1 [7.7 - 10.8] 0.00
Serum adiponectin (ng/mL) * 10911.5 ± 5554.0
[7835.7 - 13987.2]
6729.7 ± 3381.5
[4310.8 - 9148.7]
0.04
Serum urea (mg/dL) 34.2 ± 12.8 [27.1 - 41.3] 38.0 ± 7.8 [32.4 - 43.6] 0.46
Serum creatinine (mg/dL) 0.9 ± 0.2 [0.8 - 1.0] 0,9 ± 0.1 [0.7 - 1.0] 0.93
Total cholesterol (mg/dL) 193.7 ± 48.8 [166.7 - 220.8] 193.5 ± 33.2 [169.8 - 217.2] 0.36
LDL-cholesterol (mg/dL) 119.4 ± 47.0 [93.4 - 145.4] 104.3 ± 31.1 [82.0 - 126.6] 0.84
HDL-cholesterol (mg/dL) 50.8 ± 17.0 [41.4 - 60.2] 42.9 ± 11.0 [35.0 - 50.8] 0.21
Serum triglycerides (mg/dL) * 108.6 ± 48.7 [81.6 -135.6] 254.8 ± 226.4 [92.9 - 416.7] 0.04
Uric Acid (mg/dL) 5.3 ± 1.1 [4.7 - 6.0] 5.7 ± 1.2 [4.8 - 6.5] 0.60
Na (mEq/L) 140.1 ± 2.2 [138.9 - 141.3] 138.8 ± 2.0 [137.3 - 140.3] 0.17
K (mEq/L) 4.3 ± 0.5 [4.0 -4.6] 4.2 ± 0.4 [3.8 - 4.5] 0.49
UACR (mg/g) 11.3 ± 13.2 [4.0 - 18.7] 138.2 ± 229.8 [-26.2 - 302.6] 0.17
Office SBP (mmHg) 154.3 ± 21.6 [142.3 -166.2] 156.5 ± 30.6 [134.7 - 178.4] 0.93
Office DBP (mmHg) 92.9 ± 10.8 [86.9 - 98.8] 90.1 ± 18.2 [77.0 - 103.1] 0.33
  1. The values are expressed as means ± standard deviation; [95% confidence interval]; (*) Statistical significance (p < 0.05); Non-T2D: non type 2 diabetes resistant hypertension; T2D: type 2 diabetes resistant hypertension.